Literature DB >> 21436070

HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.

Delphine Sauce1, Martin Larsen, Solène Fastenackels, Michèle Pauchard, Hocine Ait-Mohand, Luminita Schneider, Amélie Guihot, Faroudy Boufassa, John Zaunders, Malika Iguertsira, Michelle Bailey, Guy Gorochov, Claudine Duvivier, Guislaine Carcelain, Anthony D Kelleher, Anne Simon, Laurence Meyer, Dominique Costagliola, Steven G Deeks, Olivier Lambotte, Brigitte Autran, Peter W Hunt, Christine Katlama, Victor Appay.   

Abstract

The mechanisms of CD4(+) T-cell count decline, the hallmark of HIV disease progression, and its relationship to elevated levels of immune activation are not fully understood. Massive depletion of CD4(+) T cells occurs during the course of HIV-1 infection, so that maintenance of adequate CD4(+) T-cell levels probably depends primarily on the capacity to renew depleted lymphocytes, that is, the lymphopoiesis. We performed here a comprehensive study of quantitative and qualitative attributes of CD34(+) hematopoietic progenitor cells directly from the blood of a large set of HIV-infected persons compared with uninfected donors, in particular the elderly. Our analyses underline a marked impairment of primary immune resources with the failure to maintain adequate lymphocyte counts. Systemic immune activation emerges as a major correlate of altered lymphopoiesis, which can be partially reversed with prolonged antiretroviral therapy. Importantly, HIV disease progression despite elite control of HIV replication or virologic success on antiretroviral treatment is associated with persistent damage to the lymphopoietic system or exhaustion of lymphopoiesis. These findings highlight the importance of primary hematopoietic resources in HIV pathogenesis and the response to antiretroviral treatments.

Entities:  

Mesh:

Year:  2011        PMID: 21436070      PMCID: PMC3109539          DOI: 10.1182/blood-2011-01-331306

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

Review 1.  The influence of human immunodeficiency virus-1 on hematopoiesis.

Authors:  A Moses; J Nelson; G C Bagby
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

2.  Peripheral blood from human immunodeficiency virus type 1-infected patients displays diminished T cell generation capacity.

Authors:  D R Clark; N M Ampel; C A Hallett; V R Yedavalli; N Ahmad; D DeLuca
Journal:  J Infect Dis       Date:  1997-09       Impact factor: 5.226

3.  Suppressive effects of recombinant human monokine induced by IFN-gamma (rHuMig) chemokine on the number of committed and primitive hemopoietic progenitors in liquid cultures of CD34+ human bone marrow cells.

Authors:  G N Schwartz; F Liao; R E Gress; J M Farber
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

Review 4.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.

Authors:  M D Hazenberg; D Hamann; H Schuitemaker; F Miedema
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

5.  Growth hormone enhances thymic function in HIV-1-infected adults.

Authors:  Laura A Napolitano; Diane Schmidt; Michael B Gotway; Niloufar Ameli; Erin L Filbert; Myra M Ng; Julie L Clor; Lorrie Epling; Elizabeth Sinclair; Paul D Baum; Kai Li; Marisela Lua Killian; Peter Bacchetti; Joseph M McCune
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

Review 6.  Immune activation and inflammation in HIV-1 infection: causes and consequences.

Authors:  V Appay; D Sauce
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

7.  Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.

Authors:  Peter W Hunt; Jason Brenchley; Elizabeth Sinclair; Joseph M McCune; Michelle Roland; Kimberly Page-Shafer; Priscilla Hsue; Brinda Emu; Melissa Krone; Harry Lampiris; Daniel Douek; Jeffrey N Martin; Steven G Deeks
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

8.  The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.

Authors:  A Aiuti; I J Webb; C Bleul; T Springer; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

9.  Impairment of T and B cell development by treatment with a type I interferon.

Authors:  Q Lin; C Dong; M D Cooper
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

10.  A human postnatal lymphoid progenitor capable of circulating and seeding the thymus.

Authors:  Emmanuelle M Six; Delphine Bonhomme; Marta Monteiro; Kheira Beldjord; Monika Jurkowska; Corinne Cordier-Garcia; Alexandrine Garrigue; Liliane Dal Cortivo; Benedita Rocha; Alain Fischer; Marina Cavazzana-Calvo; Isabelle André-Schmutz
Journal:  J Exp Med       Date:  2007-12-10       Impact factor: 14.307

View more
  62 in total

Review 1.  Hematopoietic-stem-cell-based gene therapy for HIV disease.

Authors:  Hans-Peter Kiem; Keith R Jerome; Steven G Deeks; Joseph M McCune
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

2.  Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.

Authors:  H Lim; L Kane; J B Schwartz; C S Hesdorffer; S G Deeks; N Greig; L Ferrucci; E J Goetzl
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

Review 3.  Unravelling the mechanisms of durable control of HIV-1.

Authors:  Bruce D Walker; Xu G Yu
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

4.  HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells.

Authors:  Rebecca T Veenhuis; Zachary T Freeman; Jack Korleski; Laura K Cohen; Guido Massaccesi; Alessandra Tomasi; Austin W Boesch; Margaret E Ackerman; Joseph B Margolick; Joel N Blankson; Michael A Chattergoon; Andrea L Cox
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

Review 5.  Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.

Authors:  Vincent C Lombardi; Kenny L De Meirleir; Krishnamurthy Subramanian; Sam M Nourani; Ruben K Dagda; Shannon L Delaney; András Palotás
Journal:  J Nutr Biochem       Date:  2018-04-19       Impact factor: 6.048

6.  Molecular and cellular mechanisms of Mycobacterium avium-induced thymic atrophy.

Authors:  Margarida Borges; Palmira Barreira-Silva; Manuela Flórido; Michael B Jordan; Margarida Correia-Neves; Rui Appelberg
Journal:  J Immunol       Date:  2012-08-24       Impact factor: 5.422

7.  Effect of human immunodeficiency virus infection on plasma bactericidal activity against Salmonella enterica serovar Typhimurium.

Authors:  Estela Trebicka; Nanda Kumar N Shanmugam; Anastassia Mikhailova; Galit Alter; Bobby J Cherayil
Journal:  Clin Vaccine Immunol       Date:  2014-08-13

8.  HIV and Age Do Not Synergistically Affect Age-Related T-Cell Markers.

Authors:  Shelli Farhadian; Emilie Jalbert; Yanhong Deng; Matthew B Goetz; Lesley S Park; Amy C Justice; Robert Dubrow; Brinda Emu
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

9.  HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways.

Authors:  Rachel P Simmons; Eileen P Scully; Erin E Groden; Kelly B Arnold; J Judy Chang; Kim Lane; Jeff Lifson; Eric Rosenberg; Douglas A Lauffenburger; Marcus Altfeld
Journal:  AIDS       Date:  2013-10-23       Impact factor: 4.177

10.  Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment.

Authors:  Xinyan Zhang; Peter W Hunt; Scott M Hammer; Michelle S Cespedes; Kristine B Patterson; Ronald J Bosch
Journal:  HIV Clin Trials       Date:  2013 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.